The Case for Bringing Birthweight To Adult Cardiovascular Medicine

Since Kannel and colleagues first reported on the association between serum cholesterol and coronary heart disease (CHD) risk in 1971,1 identifying clinical characteristics that predict disease onset, prognosis, and treatment response has been an objective of adult cardiovascular medicine. Risk stratification tools have, in fact, revolutionized clinical practice by guiding point-of-care decision making for therapy selection and escalation in acute myocardial infarction, heart failure, pulmonary circulatory diseases, and diabetes mellitus among other treatable conditions.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research